Share this post on:

Product Name :
IMGS-001

Search keywords :
PD L2

drugId :
null

Target Vo:
Programmed death-ligand 1

Target Vo Short Name :
PD-L1

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The University Of Texas MD Anderson Cancer Center

Active Company_Name :
ImmunoGenesis Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BMAL1 Rabbit mAb Purity & Documentation
CD38 Rabbit mAb Epigenetics
CARM1 Antibody (YA812): CARM1 Antibody (YA812) is a non-conjugated and Mouse origined monoclonal antibody about 66 kDa, targeting to CARM1 (2B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Betaine hydrochloride